Kay on Rheumatology

Jonathan Kay, MD, Professor of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts; Director of Clinical Research, Division of Rheumatology, University of Massachusetts Memorial Medical Center, Worcester, Massachusetts

'Avoid Opioids to Treat Arthritis,' Says a Rheumatologist Rheumatologic conditions can be treated effectively without the use of opioids, says Dr Jonathan Kay.
Medscape Rheumatology, January 03, 2018
Withdrawing Therapy in Patients With Arthritis Dr Jonathan Kay reviews three studies evaluating three different withdrawal strategies for patients with arthritis, from the ACR/ARHP Annual Meeting.
Medscape Rheumatology, December 12, 2017
From San Diego, A Great Debate on Biosimilars Dr Jonathan Kay provides an overview of news and views on biosimilars to be presented at ACR 2017.
Medscape Rheumatology, November 21, 2017
The March of the Biosimilars Continues Dr Jonathan Kay reviews the status of four biosimilars and stresses the importance of healthcare providers to understand their efficacy and to make them available as an additional choice for therapy.
Medscape Rheumatology, December 07, 2016
Fibromyalgia: Evidence-Based Management On the basis of new guidelines, Dr Jonathan Kay outlines his optimal approach to managing fibromyalgia.
Medscape Rheumatology, November 29, 2016
From Washington, an Update on Arthritis and Arteritis Dr Jonathan Kay discusses highlights from the 2016 American College of Rheumatology annual meeting.
Medscape Rheumatology, November 22, 2016
Calling All Twentysomethings: Your DNA Could Help Cure Disease Dr Jonathan Kay discusses the importance of biobanks in advancing basic science research and the need for more and younger people to provide samples.
Medscape Rheumatology, June 29, 2016
Encouraging News for Patients on TNF Inhibitors Dr Jonathan Kay reviews a recent analysis of Scandinavian registry data from more than 100,000 patients.
Medscape Rheumatology, June 08, 2016
Biosimilar Infliximab: One Step Closer to the Pharmacy? Dr Jonathan Kay shares his experience at the recent FDA Arthritis Advisory Committee meeting on approval of biosimilar infliximab.
Medscape Rheumatology, February 25, 2016
A New, Effective Approach to Giant Cell Arteritis Two recent studies offer encouraging results in treating giant cell arteritis.
Medscape Rheumatology, December 18, 2015
An Update on Biosimilars Biosimilars to adalimumab, etanercept, and infliximab measure up safety and efficacy-wise for rheumatology patients inadequately responsive to methotrexate.
Medscape Rheumatology, December 09, 2015
New Treatment Data for Inflammatory Arthritis Drs Jonathan Kay and Ronald van Vollenhoven discuss new arthritis treatment findings presented at this year's American College of Rheumatology annual meeting.
Medscape Rheumatology, December 07, 2015
Two Valuable Treatment Advances in Rheumatoid Arthritis Drs Jonathan Kay and Ronald van Vollenhoven discuss how biomarkers are helping guide therapy in rheumatoid arthritis.
Medscape Rheumatology, November 25, 2015
An Important Consideration in Ankylosing Spondylitis Dr Jonathan Kay talks about indication and treatment discrepancies on the ankylosing spondylitis spectrum, saying that some back pain patients end up excluded from some effective treatments.
Medscape Rheumatology, September 24, 2015
RA: 20 Years Has Made a Big Difference in Treatment With Medscape turning 20 this year, Dr Jonathan Kay looks back at the biggest advances in rheumatology over the past two decades.
Medscape Rheumatology, September 18, 2015
A Caution When Diagnosing Disease Dr Kay describes a case that illustrates the pitfalls of focusing on one set of symptoms in a patient with a very complex history.
Medscape Rheumatology, April 15, 2015
Arthritic in Arizona: A Case Dr John Kay discusses an interesting case of a patient with rheumatoid arthritis and flu-like symptoms.
Medscape Rheumatology, April 06, 2015
A New Era in Pharmacotherapy Dr Jonathan Kay discusses the ever-growing role of biosimilar therapies.
Medscape Rheumatology, April 02, 2015
Treat the Syndrome, Not the Lab Test Dr Jonathan Kay discusses an interesting case of a patient with failure to thrive, thyroiditis, lymphadenopathy, and autoimmune pancreatitis.
Medscape Rheumatology, October 15, 2014
TNF Inhibitors and Breast Cancer Recurrence Dr Jonathan Kay discusses a recent article looking at breast cancer recurrence risk in patients treated with anti-TNF agents for rheumatoid arthritis.
Medscape Rheumatology, September 30, 2014

No Results